Aquatic Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Aquatic Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	+198,532	New	+$857K	0.04%	499
2026 Q1	–	Sell	-41,457	Closed	-$135K	–	1658
2025 Q4	$135K	Buy	+41,457	New	+$140K	﹤0.01%	1090
2024 Q4	–	Sell	-38,100	Closed	-$317K	–	1513
2024 Q3	$317K	Buy	+38,100	New	+$329K	0.01%	737
2024 Q2	–	Sell	-39,400	Closed	-$342K	–	1469
2024 Q1	$342K	Buy	+39,400	New	+$267K	0.01%	639
2023 Q2	–	Sell	-3,200	Closed	-$45K	–	1605
2023 Q1	$45K	Buy	+3,200	New	+$46K	﹤0.01%	913

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Aquatic Capital Management's MRVI Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 198,532 shares worth $1.24M. The stake represents 0.04% of the portfolio and ranks #499 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in MRVI as recently as Q4 2025.

Aquatic Capital Management first reported a position in MRVI in Q1 2023 and has held it in 5 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Aquatic Capital Management held 198,532 shares of Maravai LifeSciences worth $1.24M as of Q2 2026.
Maravai LifeSciences was a new Aquatic Capital Management position in Q2 2026.
Maravai LifeSciences made up 0.04% of Aquatic Capital Management's portfolio in Q2 2026, its #499 holding.
Aquatic Capital Management first reported a position in Maravai LifeSciences in Q1 2023 and has held it in 5 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.